ZIOPHARM Oncology, Inc. (ZIOP) Posts Mixed Q1 Results

May 3, 2012 4:14 PM EDT
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q1 EPS of ($0.32), $0.09 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $80 thousand.

For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings